# Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome

Study · id `cardio:ct-nct07442071` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07442071](<https://clinicaltrials.gov/study/NCT07442071>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07442071

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 4336 participants.

## Technical summary

Registry record NCT07442071. Randomized; quadruple masking; primary purpose treatment. Start 2026-06 (anticipated); primary completion 2030-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 4336 participants (planned count; ClinicalTrials.gov record NCT07442071, source copy `cardio:ctgov-nct07442071-2026-03-02`, retrieved 2026-10-26)
- Planned start: 2026-06 (anticipated) (ClinicalTrials.gov record NCT07442071, source copy `cardio:ctgov-nct07442071-2026-03-02`, retrieved 2026-10-26)
- Primary completion: 2030-07 (anticipated) (ClinicalTrials.gov record NCT07442071, source copy `cardio:ctgov-nct07442071-2026-03-02`, retrieved 2026-10-26)
- Completion: 2030-07 (anticipated) (ClinicalTrials.gov record NCT07442071, source copy `cardio:ctgov-nct07442071-2026-03-02`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT07442071, source copy `cardio:ctgov-nct07442071-2026-03-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07442071-2026-03-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome
- Acronym: Low-EPI
- Condition: Out-of-hospital Cardiac Arrest (OHCA)
- Intervention (Drug): Epinephrine 0.5 mg intravenous bolus
- Intervention (Drug): Epinephrine 1 mg intravenous bolus
- Lead sponsor: Central Hospital, Nancy, France
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: Central Hospital, Nancy, France (`cardio:org-central-hospital-nancy-france`)

## Provenance

Content hash: 85d05ccd832a7aacbcd8334617ed28c741461f12c4c969edabbedf31c841813b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
